Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 12Meningioma 6Glioma 6Glioblastoma 4Pituitary Neoplasms 2Pinealoma 2Oligodendroglioma 2Gliosarcoma 2Craniopharyngioma 2Astrocytoma 2Prostatic Neoplasms 1Neuroblastoma 1Neurilemmoma 1Nerve Sheath Neoplasms 1Medulloblastoma 1Malignant Brain Glioma 1Hemangiopericytoma 1Head and Neck Neoplasms 1Ganglioneuroblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 8dinutuximab 7Magnetic Resonance Spectroscopy 7Topotecan 6Doxorubicin 6sargramostim 5Vincristine 5Stem Cell Transplantation 5Radiation 5Platinum 5Melphalan 5Isotretinoin 5Colony-Stimulating Factors 5Cisplatin 5Biopsy 51,2-diaminocyclohexaneplatinum II citrate 5Temozolomide 4Specimen Handling 4Irinotecan 4Etoposide 4Congresses as Topic 4Carboplatin 4Thiotepa 3Busulfan 33-Iodobenzylguanidine 3etoposide phosphate 2Razoxane 2Dexrazoxane 2temsirolimus 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroblastoma × Proton Therapy × CNS × Clear all
NCT02112617 2026-05-06

Phase II Study of Proton Radiation Therapy for Neuroblastoma

Massachusetts General Hospital

Phase NA Recruiting
30 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡